# Nemolizumab (Genetical Recombination) for S.C. Injection (ミチーガ皮下注用３０ｍｇバイアル)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4490408D1021). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4490408D1021
- **Product name (Japanese):** ミチーガ皮下注用３０ｍｇバイアル
- **English title:** Nemolizumab (Genetical Recombination) for S.C. Injection
- **Active ingredient:** ネモリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Nemolizumab (Genetical Recombination)
- **Strength / unit:** ３０ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 44 Antiallergic agents (アレルギー用薬) › 449 Other antiallergic agents (その他のアレルギー用薬)
- **Manufacturer:** Maruho (マルホ)
- **NHI price (reference only):** JPY 67112 per ３０ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4490408D1021
- **JSON:** https://www.nifujipharma.com/api/drugs/4490408D1021

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Nemolizumab%20(Genetical%20Recombination)%20for%20S.C.%20Injection%20(%E3%83%9F%E3%83%81%E3%83%BC%E3%82%AC%E7%9A%AE%E4%B8%8B%E6%B3%A8%E7%94%A8%EF%BC%93%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%90%E3%82%A4%E3%82%A2%E3%83%AB)%20%2F%20YJ%204490408D1021#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Nemolizumab (Genetical Recombination)

- [Nemolizumab (Genetical Recombination) for S.C. Injection 60mg Syringe (ミチーガ皮下注用６０ｍｇシリンジ)](https://www.nifujipharma.com/drugs/4490408G1028) — ６０ｍｇ１筒, Maruho